![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 1-(17-(acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
2. Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-, 17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-
3. Esmeron
4. Esmerone
5. Org 9426
6. Org-9426
7. Org9426
8. Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide
9. Rocuronium
10. Zemuron
1. 119302-91-9
2. Zemuron
3. Esmeron
4. Rocuronium (bromide)
5. Org 9426
6. Org-9426
7. Chebi:8885
8. I65mw4ofhz
9. 1-allyl-1-(3alpha,17beta-dihydroxy-2beta-morpholino-5alpha-androstan-16beta-yl)pyrrolidinium Bromide, 17-acetate
10. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl] Acetate;bromide
11. Pyrrolidinium, 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)-, Bromide
12. Rocuronium Hydrobromide
13. 1-[17b-(acetyloxy)-3a-hydroxy-2b-(4-morpholinyl)-5a-androstan-16b-yl]-1-(2-propenyl)pyrrolidinium Bromide
14. Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide
15. Ncgc00167433-01
16. Unii-i65mw4ofhz
17. Org9426
18. Eslax
19. Rocuroniumbromide
20. Zemuron (tn)
21. Mfcd00867768
22. Rocuronium Bromide [usan:usp:inn:ban]
23. Rocuronium Bromide - Ep
24. Dsstox_cid_3566
25. Org 9426 (bromide)
26. Dsstox_rid_77083
27. Dsstox_gsid_23566
28. Schembl41320
29. (+)-rocuronium Bromide
30. Rocuronium Bromide [mi]
31. Chembl1200648
32. Dtxsid7023566
33. Rocuronium Bromide [inn]
34. Rocuronium Bromide [jan]
35. Rocuronium Bromide [usan]
36. Hms3884o13
37. Rocuronium Bromide [vandf]
38. Rocuronium Bromide [mart.]
39. Rocuronium Bromide (jan/usp/inn)
40. Rocuronium Bromide [usp-rs]
41. Rocuronium Bromide [who-dd]
42. Tox21_112437
43. Bdbm50248153
44. S1397
45. Akos025149635
46. Ac-2004
47. Ccg-270222
48. Cs-1467
49. Rocuronium Bromide [orange Book]
50. Rocuronium Bromide [ep Monograph]
51. 1-((2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidin-1-ium Bromide
52. 111ge014
53. As-13323
54. Br177300
55. Hy-17440
56. Rocuronium Bromide [usp Monograph]
57. Bcp0726000028
58. Cas-119302-91-9
59. R0099
60. D00765
61. Q-101010
62. Q27108171
63. Rocuronium Bromide, >=98% (perchloric Acid Titration)
64. Rocuronium Bromide, European Pharmacopoeia (ep) Reference Standard
65. Rocuronium Bromide, United States Pharmacopeia (usp) Reference Standard
66. Rocuronium For Peak Identification, European Pharmacopoeia (ep) Reference Standard
67. (2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-morpholin-4-yl-16-(1-prop-2-en-1-ylpyrrolidinium-1-yl)androstane Bromide
68. 1-((2s,3s,8r,9s,10s,13s,14s,16s,17r)-17-acetoxy-3-hydroxy-10,13-dimethyl-2-morpholinohexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-allylpyrrolidinium Bromide
69. 1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(4-morpholinyl)-androstan-16-yl]-1(2-propenyl)pyrrolidinium Bromide
70. 1-[17beta-acetyloxy-3alpha-hydroxy-2beta-(4-morpholinyl)-5alpha-androstan-16beta-yl]-1-(2-propenyl)pyrrolidinium Bromide
71. 1-allyl-1-(3.alpha.,17.beta.-dihydroxy-2.beta.-morpholino-5.alpha.-androstan-16.beta.-yl)pyrrolidinium Bromide, 17-acetate
72. 17beta-(acetyloxy)-3alpha-hydroxy-2beta-(morpholin-4-yl)-16beta-[1-(prop-2-en-1-yl)pyrrolidinium-1-yl]-5alpha-androstane
73. 17beta-acetoxy-16beta-(1-allylpyrrolidinium-1-yl)-3alpha-hydroxy-2beta-(morpholin-4-yl)-5alphaandrostane
74. Pyrrolidinium, 1-((2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, Bromide
Molecular Weight | 609.7 g/mol |
---|---|
Molecular Formula | C32H53BrN2O4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 608.31887 g/mol |
Monoisotopic Mass | 608.31887 g/mol |
Topological Polar Surface Area | 59 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 898 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Rocuronium bromide |
PubMed Health | Rocuronium (Injection) |
Drug Classes | Musculoskeletal Agent |
Drug Label | Rocuronium bromide injection is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium bromide USP is chemically designated as 1-[17-(acetyloxy)-3-hydroxy-2-(4-m... |
Active Ingredient | Rocuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/5ml (10mg/ml); 100mg/10ml (10mg/ml) |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Sandoz; Teva Pharms; Fresenius Kabi Usa; Tamarang; Mylan Institutional |
2 of 4 | |
---|---|
Drug Name | Zemuron |
Drug Label | ZEMURON (rocuronium bromide) injection is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium bromide is chemically designated as 1-[17-(acetyloxy)-3-hydroxy-2... |
Active Ingredient | Rocuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/5ml (10mg/ml); 100mg/10ml (10mg/ml) |
Market Status | Prescription |
Company | Organon Usa |
3 of 4 | |
---|---|
Drug Name | Rocuronium bromide |
PubMed Health | Rocuronium (Injection) |
Drug Classes | Musculoskeletal Agent |
Drug Label | Rocuronium bromide injection is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium bromide USP is chemically designated as 1-[17-(acetyloxy)-3-hydroxy-2-(4-m... |
Active Ingredient | Rocuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/5ml (10mg/ml); 100mg/10ml (10mg/ml) |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Sandoz; Teva Pharms; Fresenius Kabi Usa; Tamarang; Mylan Institutional |
4 of 4 | |
---|---|
Drug Name | Zemuron |
Drug Label | ZEMURON (rocuronium bromide) injection is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium bromide is chemically designated as 1-[17-(acetyloxy)-3-hydroxy-2... |
Active Ingredient | Rocuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/5ml (10mg/ml); 100mg/10ml (10mg/ml) |
Market Status | Prescription |
Company | Organon Usa |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
M - Musculo-skeletal system
M03 - Muscle relaxants
M03A - Muscle relaxants, peripherally acting agents
M03AC - Other quaternary ammonium compounds
M03AC09 - Rocuronium bromide